SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 10, 2006--Hana Biosciences (NASDAQ:HNAB - News), a biopharmaceutical company focused on advancing cancer care, announced today that Dr. Greg Berk, Senior Vice President and Chief Medical Officer, will present a company update at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Wednesday, July 12th, at 1:10pm EDT at The Mandarin Oriental Hotel in New York City, NY.
